• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA、免疫遗传学、药物遗传学与个性化医疗。

HLA, immunogenetics, pharmacogenetics and personalized medicine.

机构信息

Immunology, Inserm 940-IUH-Hopital Saint-Louis, Paris, France.

出版信息

Vox Sang. 2011 Jan;100(1):163-6. doi: 10.1111/j.1423-0410.2010.01438.x.

DOI:10.1111/j.1423-0410.2010.01438.x
PMID:21175666
Abstract

Displaying the highest level of diversity of any functional genetic complex with medical impact, the HLA system represents a landmark and a model for the development of predictive and preventive medicine. The massive amount of data which will soon be obtained through new high through put technologies for individual genomes and transcriptomes challenges the HLA and medicine paradigm. Systems biology approach and integrative methodologies will undoubtedly be needed to unravel the ever growing number of HLA and diseases associations and the role of immunogenetics in transplantation and other allogeneic cell therapies. Also HLA, immunogenetics and pharmacogenetics are merging to bring to the individual patient tailored and personalized treatment. Providing insights into the complexities of predictive, preventive participatory and personalized medicine, the role of the HLA system will be consolidated at the forefront of the newer medicine.

摘要

HLA 系统是具有医学影响的功能基因复合体中多样性最高的,它代表了预测性和预防性医学发展的一个里程碑和模型。通过新的高通量技术获取个体基因组和转录组的海量数据,这给 HLA 和医学领域带来了挑战。为了揭示 HLA 与疾病之间越来越多的关联,以及免疫遗传学在移植和其他同种异体细胞治疗中的作用,系统生物学方法和综合方法无疑是必要的。此外,HLA、免疫遗传学和药物遗传学正在融合,为个体患者带来量身定制的个性化治疗。HLA 系统在预测性、预防性、参与性和个性化医学的复杂性方面提供了深入的见解,它将在新医学的前沿得到巩固。

相似文献

1
HLA, immunogenetics, pharmacogenetics and personalized medicine.HLA、免疫遗传学、药物遗传学与个性化医疗。
Vox Sang. 2011 Jan;100(1):163-6. doi: 10.1111/j.1423-0410.2010.01438.x.
2
Immunoinformatics and systems biology methods for personalized medicine.用于个性化医疗的免疫信息学和系统生物学方法。
Methods Mol Biol. 2010;662:203-20. doi: 10.1007/978-1-60761-800-3_10.
3
Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.中医个性化医学的未来展望:系统生物学方法。
Complement Ther Med. 2012 Feb-Apr;20(1-2):93-9. doi: 10.1016/j.ctim.2011.10.007. Epub 2011 Nov 30.
4
Immunogenetics.免疫遗传学
Curr Opin Hematol. 1994 Nov;1(6):429-34.
5
[Lexical fields of predictive and personalized medicine].[预测性与个性化医学的词汇领域]
Ann Biol Clin (Paris). 2012 Nov-Dec;70(6):651-8. doi: 10.1684/abc.2012.0767.
6
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.疫苗免疫反应的异质性:免疫遗传学的作用及疫苗组学这一新兴领域
Clin Pharmacol Ther. 2007 Dec;82(6):653-64. doi: 10.1038/sj.clpt.6100415. Epub 2007 Oct 31.
7
Personalized medicine: a paradigm for a sustainable pharmaceutical industry?个性化医疗:可持续制药行业的一种模式?
Curr Opin Drug Discov Devel. 2009 Jul;12(4):443-5.
8
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory.个人视角下的系统医学与主动的 P4 医学的出现:预测性、预防性、个性化和参与性。
N Biotechnol. 2012 Sep 15;29(6):613-24. doi: 10.1016/j.nbt.2012.03.004. Epub 2012 Mar 18.
9
P4 medicine: the future around the corner.P4 医学:未来已来。
Arch Bronconeumol. 2011 Jan;47(1):35-40. doi: 10.1016/j.arbres.2010.09.009. Epub 2010 Dec 28.
10
From pharmacogenomics and systems biology to personalized care: a framework of systems and dynamical medicine.从药物基因组学和系统生物学到个性化医疗:系统与动态医学框架
Methods Mol Biol. 2014;1175:3-17. doi: 10.1007/978-1-4939-0956-8_1.

引用本文的文献

1
Association of HLA-C*07:359 with HLA-A, -B, and -DRB1 alleles in Taiwanese.台湾人群中HLA-C*07:359与HLA-A、-B及-DRB1等位基因的关联
Tzu Chi Med J. 2024 Mar 26;36(2):166-174. doi: 10.4103/tcmj.tcmj_288_23. eCollection 2024 Apr-Jun.
2
A Comprehensive Review of and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine.药物性皮疹伴嗜酸性粒细胞增多和系统症状(DRESS)及严重皮肤不良反应的综合综述:对临床药物基因组学和精准医学的启示
Pharmaceuticals (Basel). 2021 Oct 25;14(11):1077. doi: 10.3390/ph14111077.
3
The deduced probable HLA-C*03:187-associated human leukocyte antigen haplotype (A*24:02-B*35:01-C*03:187-DRB1*11:01) revealed in Taiwanese unrelated hematopoietic bone marrow stem cell donors.
在台湾非亲属造血骨髓干细胞供者中发现的推断出的可能与HLA-C*03:187相关的人类白细胞抗原单倍型(A*24:02-B*35:01-C*03:187-DRB1*11:01)。
Tzu Chi Med J. 2019 Sep 30;32(3):254-257. doi: 10.4103/tcmj.tcmj_106_19. eCollection 2020 Jul-Sep.
4
HLA-A*29:01-B*07:05-C*15:29*DRB1*10:01-DQB1*05:01, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen-C low-incidence allele C*15:29 in Taiwanese individuals.HLA - A*29:01 - B*07:05 - C*15:29*DRB1*10:01 - DQB1*05:01,一种推测可能的人类白细胞抗原单倍型,与台湾个体中一种人类白细胞抗原 - C低发生率等位基因C*15:29相关。
Tzu Chi Med J. 2019 Apr-Jun;31(2):86-89. doi: 10.4103/tcmj.tcmj_111_18.
5
Human leukocyte antigen-A*33:03-B*58:01-DRB1*15:140, a deduced probable human leukocyte antigen haplotype in association with a human leukocyte antigen low-incidence allele DRB1*15:140 in Taiwanese individuals: A case analysis.人类白细胞抗原-A*33:03-B*58:01-DRB1*15:140,一种推导得出的可能与台湾个体中人类白细胞抗原低发生率等位基因DRB1*15:140相关的人类白细胞抗原单倍型:病例分析。
Tzu Chi Med J. 2019 Jan-Mar;31(1):20-22. doi: 10.4103/tcmj.tcmj_72_18.
6
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.宫颈肿瘤发生与免疫应答基因多态性:综述
J Immunol Res. 2017;2017:8913860. doi: 10.1155/2017/8913860. Epub 2017 Feb 9.
7
Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.肿瘤坏死因子基因多态性与白塞病易感性:一项更新的荟萃分析。
Mol Vis. 2013 Sep 12;19:1913-24. eCollection 2013.
8
Molecular integrity and global gene expression of breast and lung cancer stem cells under long-term storage and recovery.长期储存与复苏条件下乳腺癌和肺癌干细胞的分子完整性及整体基因表达
Cell Tissue Bank. 2013 Jun;14(2):175-86. doi: 10.1007/s10561-012-9315-3. Epub 2012 May 18.
9
Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro.系统生物学方法诱导移植耐受:利用 RNA 干扰(RNAi)体外敲低 Jurkat 和 HeLa 细胞中枢纽基因的概念验证实验。
J Surg Res. 2012 Jul;176(1):e41-6. doi: 10.1016/j.jss.2011.12.002. Epub 2011 Dec 22.